The Clinical Center for Targeted Therapy offers clinical trials of regional therapy (chemotherapy and targeted agents) for patients with cancer that has metastasized but is still limited predominantly to a specific body organ or region.
Giving a compound regionally allows delivery of higher concentrations of the drug to the tumor bed while limiting the side effects, in order to try and improve response.
We offer clinical trials of regional therapy as follows:
Hepatic arterial infusion, which delivers treatment to the liver, for patients whose cancer is predominantly in the liver.
Intraperitoneal therapy, for patients whose cancer manifests mostly as peritoneal carcinomatosis.
For referrals and to get an appointment, contact: Christie Carver-Fryer (Patient Access Supervisor) at (713)792-1160.